Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Hepatitis C Drug (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) Market 2015-2021 - Research and Markets

Research and Markets
Posted on: 19 Aug 16

Research and Markets has announced the addition of the "Hepatitis C Drug Market 2015 - 2021" report to their offering.

The report covers forecast and analysis for the market on a global and regional level. The study provides historic data of hepatitis C drug market 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion). The study includes drivers and restraints for the hepatitis C drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hepatitis C drug market on a global level.

In order to give the users of this report a comprehensive view on the hepatitis C market, we have included a detailed competitive scenario and type portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's Five Forces model for the hepatitis C drug market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the hepatitis C drug market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Hospitals, private labs, physician offices, public health labs, and blood banks are the key application of the hepatitis C drug market.

Some of the key player in the hepatitis C drug market includes Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Hepatitis C Drug Market: Industry Analysis

4. Global hepatitis C drug market: Competitive Landscape

5. Global hepatitis C market: Application Overview

6. Global hepatitis C drug market: Regional Analysis

7. Company Profiles

8. Patents

For more information about this report visit http://www.researchandmarkets.com/research/gjqtbx/hepatitis_c_drug

Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs

View source version on businesswire.com: http://www.businesswire.com/news/home/20160819005651/en/

Business Wire
www.businesswire.com

Last updated on: 19/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.